Structural characterization of transfection nanosystems based on tricationic surfactants and short double stranded oligonucleotides

For several years cationic surfactants have been the subjects of extensive studies as potential transgene carriers to be used in gene therapy. We report the formation of stable complexes between 21 base pairs oligonucleotides – siRNA, enhancing DMPK gene, and dsDNA and two tricationic surfactants (1...

Full description

Saved in:
Bibliographic Details
Published inBiochemical and biophysical research communications Vol. 518; no. 4; pp. 706 - 711
Main Authors Andrzejewska, Weronika, Wilkowska, Michalina, Peplińska, Barbara, Skrzypczak, Andrzej, Kozak, Maciej
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 22.10.2019
Subjects
Online AccessGet full text
ISSN0006-291X
1090-2104
1090-2104
DOI10.1016/j.bbrc.2019.08.114

Cover

More Information
Summary:For several years cationic surfactants have been the subjects of extensive studies as potential transgene carriers to be used in gene therapy. We report the formation of stable complexes between 21 base pairs oligonucleotides – siRNA, enhancing DMPK gene, and dsDNA and two tricationic surfactants (1,2,3-propanetri[oxymethyl-3-(1-dodecylimidazolium)]chloride and 1,2,3-propanetri[(oxymethyl)dimethyldodecylammonium]chloride. Structural studies by SAXS and TEM have shown that the dominant structure of the obtained lipoplexes is based on hexagonal, lamellar and cubic phases, packed in highly ordered aggregates. It has been established that tricationic surfactants can be used as siRNA carriers in gene therapy. •Tricationic surfactants form stable complexes with oligonucleotides (siRNA, dsDNA).•SAXS and TEM have shown the dominant structure of the obtained lipoplexes.•It was confirmed that tricationic surfactants can be used as siRNA carriers.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-291X
1090-2104
1090-2104
DOI:10.1016/j.bbrc.2019.08.114